1A0nastasslades EG,Howarth DHJ,Shanks D,et al.Monitoring of iron require ment in renal patient on erythropoietin.Nephrol Dial Transplant,1993,8:846.
2Levin NW,Lazanis JM,Missensson AR,et al.National cooperative rHu erythr opoietin study in patient with chronic renal failure:an interm report Am J Kidne y Dis,1993,22(suppl 1):3.
1[1]Eschbach JW,Egrie JC,Downing MR,et al.Correction of the anemia of end-stage renal disease withrecombinant human erythropoietin.N Engl J Med，1987，316:73
2[2]Anastasslades EG,Howarth DHJ,Shanks D,et al.Monitoring of iron requirements in renal patient on erythropoietin .Nephrol Dial Transplant，1993，8:846
3[3]Levin NW,Lazarus JM,Missensson AR,et al.National cooperative rHu-erythropoietin study in patients with chronic renal failure:an interm report.Am J Kindey Dis，1993，22(Suppl 1):3
4[4]Iain C,Macdougall,Beatriz T,et al.A randomized controlled study of iron supplementation in patients treated with erythropoietin.Kidney Int,1996,50:1694
5[5]Cavill I,Macdougall IC.Erythropoiesis and iron supply in patients treated with erythropoietin.Erythropoiesis，1992，3:50
6[6]David B,Van Wyck MD,Gullio Cavallo MD,et al.Safety and efficaay of iron sucrose in patients sensitive to iron dextran:North American clinical trial.AM J Kindey Dis,2000,36(1):88
7[7]Allen R,Nissensson MD,Robert M,et al.Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients.Am J Kidney Dis，1999，133(3):471
1Sub H,Wadhwa NK.Iron dextran treatment in peritoneal dialysis patients on erythropoietin[J].Adv Perit Dial,1992,8:464-466.
2Working Party for European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure.European best practice guidelines for the management of anaemia in patients with chronic renal failure[J].Nephrol Dial Transplant,1999,14(suppl 5):1-50.
3European Survey on Anaemia Management(ESAM)[J].Nephrol Dial Transplant,2000,15(suppl 4):1-76.
4Sunder-Plassmann G,Horl WH.Erythropoietin and iron[J].Clin Nephrol,1997,47:141-157.
5National Kidney Foundation.K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease,2000[J].Am J Kidney Dis,2001,37(suppl 1):S182-S238.
6Sunder-Plassmann G,Horl WH.ImpoRTance of iron supply for erythropoiesis[J].Nephrol Dial Transplant,1995,10:2070-2076.
7Fishbane S,Ungureanu V,Macsaka JK,et al.Safety of intravenous iron dextran in henmdialysis patients[J].Am J Kidney Dis,1996,28:529-534.
8Gupta A,Amin NB,Besarab A,et al.Dialysis iron therapy:Infusion of soluble ferric pyrophosphate via the dialysate during hemodialysis[J].Kidney Int,1999,55:1891.
9Gupta A.Iron infusion into the arterial blood line during haemodialysis:a novel method to remove free iron and reduce oxidative damage[J].Nephrol Dial Transplant,2000,15:1482.
10Sukandar E,Gondodiputro R.The role of intramuscular administration iron-dextran to eontol hyperphosphataemia in haemodialysis oatients[J].Nephrology Dialysis Transplantation.1999,14:A32.
